Diebold Nixdorf Inc (DBD)

Cost of Revenue

$691.20M

Quarterly · Period ending: · USD

DBD logo

DBD Cost of Revenue

Latest reported$691.20M
DBD Quarterly Cost of Revenue ($0.00 → $691.20M)
High-resolution chart · PNG

DBD cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Diebold Nixdorf Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
290,575,000
266,697,000
312,355,000
321,845,000
292,290,000
222,062,000
220,200,000
191,500,000
179,400,000
176,600,000
198,000,000
180,800,000
173,200,000
189,100,000
209,800,000
202,500,000
191,600,000
164,600,000
182,700,000
167,400,000
153,500,000
135,700,000
154,600,000
133,600,000
125,100,000
126,100,000
142,900,000
117,300,000
117,500,000
113,300,000
118,500,000
102,000,000
97,500,000
87,500,000
97,200,000
82,400,000
86,200,000
76,400,000
85,200,000
80,900,000
80,100,000
71,100,000
81,700,000
81,100,000
83,400,000
74,900,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.